Venlafaxine dependence in a patient with a history of alcohol and amineptine misuse

Addiction

Volumn 103, Issue 9, 2008, Pages 1572-1574

  Quaglio, Gianluca ^a   Schifano, Fabrizio ^b   Lugoboni, Fabio ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

Addiction; Antidepressants; Dependence; Substance abuse; Substance dependence; Venlafaxine; Withdrawal symptoms

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; AMINEPTINE; AMPHETAMINE; BICARBONATE; CALCIUM; CHLORIDE; CHOLESTEROL; CREATININE; DOPAMINE; DOPAMINE UPTAKE INHIBITOR; DULOXETINE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; POTASSIUM; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SODIUM; THYROID HORMONE; VENLAFAXINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; ARTICLE; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CASE REPORT; CHLORIDE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DEPRESSION; DROWSINESS; DRUG DEPENDENCE; DRUG DETOXIFICATION; DRUG DOSE INCREASE; DRUG MISUSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; LEUKOCYTE COUNT; LIVER FUNCTION; MALE; NAUSEA; POTASSIUM BLOOD LEVEL; QT PROLONGATION; RECURRENT DISEASE; SEROTONINERGIC SYSTEM; SIDE EFFECT; SODIUM BLOOD LEVEL; SYMPTOMATOLOGY; TABLET; THROMBOCYTE COUNT; THYROID HORMONE BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; WITHDRAWAL SYNDROME;

ALCOHOL DETERRENTS; ALCOHOLISM; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CYCLOHEXANOLS; DEPRESSIVE DISORDER; DIBENZOCYCLOHEPTENES; DISULFIRAM; HUMANS; MALE; MIDDLE AGED; PRESCRIPTION DRUGS; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 49249083698     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2008.02266.x     Document Type: Article

References (14)

1. Wyeth. Venlafaxine hydrochloride. Product's label. Philadelphia, PA, USA 2006.
2. Sattar S. P., Grant K. M., Bhatia S. C. A case of venlafaxine abuse. N Engl J Med 2003 348:764 5.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC:American Psychiatric Association 1994.
4. Haddad P. Do antidepressants have any potential to cause addiction? J Psychopharmacol 1999 13:300 7.
5. Prieto J. M., Gost A., Obiols J., Caycedo N. Amineptine dependence and schizophrenia. Biol Psychiatry 1994 36:266 8.
6. Davids E., Roschke J., Klawe C., Grunder G., Schmoldt A. Tranylcypromine abuse associated with delirium and thrombocytopenia. J Clin Psychopharmacol 2000 20:270 1.
7. Prahlow J. A., Landrum J. E. Amitriptyline abuse and misuse. Am J Forensic Med Pathol 2005 26:86 8.
8. Taieb O., Larroche C., Dutray B., Baubet T., Moro M. R. Fluoxetine dependence in a former amineptine abusers. Am J Addict 2004 13:498 500.
9. Leterme L., Singlan Y. S., Auclair V., Le Boisselier R., Frimas V. Misuse of tianeptine: five cases of abuse. Ann Med Interne 2003 154:S58 63.
10. Lepping P., Menkes D. B. Abuse of dosulepin to induce mania. Addiction 2007 102:1166 7.
11. Pinzani V., Ginies E., Robert L., Peyriere H., Abbar M., Blavac J. P. Venlafaxine withdrawal syndrome: report of six cases and review of the literature. Rev Med Interne 2000 21:282 4.
12. Johnson H., Bouman W. P., Lawton J. Withdrawal reaction associated with venlafaxine. BMJ 1998 317:787.
13. Bymaster F. P., Dreshfield-Ahmad L. J., Threlkeld P. G., Shaw J. L., Thompson L., Nelson D. L. et al. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology 2001 25:871 80.
14. Medwatch. The FDA Medical Products Reporting Program. Summary of Safety-Related Drug Labelling Changes Approved by FDA. Rockville, MD:US Food and Drug Administration 2000.